What are the main achievements of the ALS research using U-Factor® liquid?

The world's first medical evidence-based prospective intervention study on systemic administration of U-Factor® liquid to ALS patients was completed, demonstrating safety and the potential for improved respiratory function and suppressed progression in some cases.

What is U-Factor® liquid?

It is a supernatant liquid produced during the culture of human dental pulp-derived stem cells, rich in "neurotrophic factors" that may contribute to the improvement of ALS symptoms, and has neuroprotective and immunomodulatory effects.

AI News NQ Analysis

[World First] U-Factor® liquid used in ALS (Amyotrophic Lateral Sclerosis) prospective intervention study results presented at academic conference

NQ Score 81/100

AI Summary (NQ-processed)

U-Factor Holdings Co., Ltd. announced that Dr. Yasuhiro Seta, Director of Hitonowa Medical, presented the results of a prospective intervention study using human dental pulp-derived stem cell conditioned medium (U-Factor® liquid) for ALS (Amyotrophic Lateral Sclerosis) at the "25th Annual Meeting of the Japanese Society for Regenerative Medicine." This study is a groundbreaking, world-first achievement demonstrating new treatment possibilities for improving function in the intractable disease ALS. No serious side effects were observed during 12 weeks of continuous administration, and improvement in respiratory function and suppression of progression were noted in some cases. Our group will accelerate the optimization and social implementation of this treatment based on these findings.

AI analysis data is not yet available.

Frequently Asked Questions

Q: What are the main achievements of the ALS research using U-Factor® liquid?: A: The world's first medical evidence-based prospective intervention study on systemic administration of U-Factor® liquid to ALS patients was completed, demonstrating safety and the potential for improved respiratory function and suppressed progression in some cases.
Q: What is U-Factor® liquid?: A: It is a supernatant liquid produced during the culture of human dental pulp-derived stem cells, rich in "neurotrophic factors" that may contribute to the improvement of ALS symptoms, and has neuroprotective and immunomodulatory effects.